| 000 | 01113 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250518075916.0 | ||
| 264 | 0 | _c20200128 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1538-8689 | ||
| 024 | 7 |
_a10.1097/01.NURSE.0000651608.77613.29 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHussar, Daniel A | |
| 245 | 0 | 0 |
_aNew Drugs 2020, part 1. _h[electronic resource] |
| 260 |
_bNursing _cFeb 2020 |
||
| 300 |
_a31-38 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzofurans _xtherapeutic use |
| 650 | 0 | 4 |
_aCarbamates _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPhenylalanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 |
_aPurines _xtherapeutic use |
| 650 | 0 | 4 |
_aTetracyclines _xtherapeutic use |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tNursing _gvol. 50 _gno. 2 _gp. 31-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.NURSE.0000651608.77613.29 _zAvailable from publisher's website |
| 999 |
_c30477355 _d30477355 |
||